Clinical trials: Patients Undergoing Diagnostic EGD
Procedural Sedation, Endoscopy
Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy
The purpose of this study was to assess the safety and efficacy of CNS 7056 as a procedural sedative at three dose levels compared to midazolam during a diagnostic upper GI endoscopy.
- Trial name
- NCT00869440
- Testing
- CNS 7056, Midazolam
- Where
- 7 sites in United States
- Volunteers
- 100 people
- Sponsor
- Paion UK Ltd.
Sedation
A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
The purpose of this study is to find out the optimal dose for Remimazolam Tosilate as a procedural sedative during a diagnostic upper GI endoscopy and to assess its efficacy and safety profile comparing to propofol.
- Trial name
- NCT03003884
- Testing
- Remimazolam Tosilate, Propofol
- Where
- China
- Volunteers
- 153 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Sedation
Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
The purpose of this study is to evaluate the safety and efficacy of the sedation for Remimazolam or Propofol in patients undergoing diagnostic upper GI endoscopy.
- Trial name
- NCT03425474
- Testing
- Remimazolam Tosilate, Propofol
- Where
- China
- Volunteers
- 378 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.